MORE than three decades have passed since the first attempt to treat myasthenia gravis with veratrum alkaloids. 1,2 At that time "Tinctura Veratri," given either intravenously or by mouth, was found ...

Former tennis star Monica Seles recently revealed she is living with the rare disease myasthenia gravis, which affects 12 in ...

The ongoing EPIC clinical trial is the first randomized head-to-head comparison of two neonatal Fc receptor (FcRn)-targeting ...

DEAR DR. ROACH: I have bulbar myasthenia gravis, which makes it difficult to eat. Can you tell me something about this disease and the odds of it spreading elsewhere in my body? — C.B. ANSWER: ...

New phase 3 data show meaningful improvement in antibody-negative myasthenia gravis, for which treatment options are limited ...

Myasthenia gravis (MG) has been treatable for nearly 100 years. In 1934, the Scottish doctor Mary Broadfoot Walker, MD, discovered that the drug physostigmine improved muscle function in people with ...

Dear Dr. Roach • I have bulbar myasthenia gravis, which makes it difficult to eat. Can you tell me something about this disease and the odds of it spreading elsewhere in my body? — C.B. Answer • ...

A collaborative approach to myasthenia gravis This chronic autoimmune disorder is caused by antibodies that block muscle cells from receiving neurotransmitters from the nerve cell. Accreditation for ...

Comorbidities and older age increase the risk of severe COVID-19 in MG patients, but not susceptibility to infection. MG treatments, including corticosteroids and immunosuppressants, do not heighten ...

SAN FRANCISCO -- Investigational gefurulimab met its primary efficacy endpoint in adults with anti-acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (MG), topline data from ...

Two open-label extension studies show that the FcRn blocker nipocalimab has durable efficacy and sustained symptom control ...